CELLUS is a Chilean regenerative medicine company focused on developing and commercializing innovative cell therapies for improving the management of a variety of invalidating inflammatory disorders and injuries with undermet medical needs.

Our company developed a proprietary and cost effective 3D spheroids technology to rapidly and efficiently obtain and activate large amounts of clinical grade adult stem cells utilizing an oxygen controlled atmosphere and without the need of animal derived products.